Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:
http://www.novonordisk-us.com/documents/promotion_page/document/diabetes_innovation_awards.asp
Sponsor/Award: NOVO NORDISK INC. - DIABETES INNOVATION AWARD PROGRAM - EARLY EXPLORATION AWARD - 2011 SUMMER COMPETITION

Grant Amount: 2 YEARS
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: Jul 25, 2011
Sponsor's: Aug 01, 2011

Subject Areas: Protein Science, Diabetes
Description:

Novo Nordisk offers two types of research funding opportunities under the Novo Nordisk Diabetes Innovation Award Program: Early Exploration and Proof of Principle (PoP). The awards are reserved for nonclinical research only and support both new and established scientists exploring novel hypotheses in protein-based therapeutics and technologies for diabetes and obesity.

Types of research eligible for support : New biological targets amenable to protein-based therapeutics; Research exploring novel protein effects and functions; Research exploring novel protein effects and functions; Protein-based science technologies including oral and injection delivery concepts. Protein-based science technologies include (but are not limited to) research in protein expression, purification, modification and stability. Delivery concepts cover research into carriers for protein delivery, carrier-protein interactions and stability, as well as exploration of biological barriers to protein delivery.

Application Details:

Applicants must hold full-time faculty positions or the equivalent at accredited Universityaffiliated institutions or the equivalent within the United States or Canada. Applicants must hold a PhD, MD, PharmD degree or, for other professionals, the equivalent health, science or engineering related degree. Applicants must be United States citizens, Canadian citizens or possess permanent resident status in the United States or Canada.

Electronic applications must be submitted by 8:00 PM Eastern Time on August 1st 2011. Applications received after the deadline will be administratively disapproved. Applications must be e-mailed to the program office at diabetesinnovation@novonordisk.com stating the type of award being applied for in the subject line. Applicants must have the host institution?s approval prior to submission, including a statement of commitment that adequate lab space and facilities will be made available for the conduct of the research proposal.

INDIRECT COSTS OF 40% MUST BE INCLUDED IN THE PROJECT BUDGET

NOTE: All Letters of Intent and Full Applications must be processed through Research Development & Services for institutional approval. Requests for Institutional approvals should be received no less than 3 days prior to the posted Sponsor deadline. A ROLA Proposal (bearing applicant, Chair and Dean electronic approvals) is required for each submission.
Western Contacts: Russelo,Theresa M
Pocock,Katy

Sponsor Contacts:

DIABETESINNOVATION@NOVONORDISK.COM
100 College Road West
Princeton, New Jersey, United States
609 987-5800